Hinge Health, Inc. (HNGE)

Market Cap	3.35B
Revenue (ttm)	587.86M +50.6%
Net Income	-424.09M
EPS	-7.77
Shares Out	77.37M
PE Ratio	n/a
Forward PE	21.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,168
Open	42.86
Previous Close	43.32
Day's Range	42.86 - 43.86
52-Week Range	30.08 - 62.18
Beta	n/a
Analysts	Strong Buy
Price Target	58.25 (+34.65%)
Earnings Date	May 5, 2026

About HNGE

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, C...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: May 22, 2025
• Employees: 1,437
• Stock Exchange: NYSE
• Ticker Symbol: HNGE
• Website: https://www.hingehealth.com

Financial Performance

In 2025, Hinge Health's revenue was $587.86 million, an increase of 50.58% compared to the previous year's $390.40 million. Losses were -$424.09 million, 3453.9% more than in 2024.

Analyst Summary

According to 17 analysts, the average rating for HNGE stock is "Strong Buy." The 12-month stock price target is $58.25, which is an increase of 34.65% from the latest price.

Price Target

$58.25

(34.65% upside)

Analyst Consensus: Strong Buy